Tenzing Acquisition Corp. Uncategorized Contracts & Agreements

16 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities
Tenzing Acquisition Corp.
Pharmaceuticals
2024
Description of Securities
Tenzing Acquisition Corp.
Pharmaceuticals
2023
Description of Securities
Tenzing Acquisition Corp.
Pharmaceuticals
2021
Letter Agreement, dated as of December 14, 2020, by and between the Company, Maxim Group LLC and Maxim Partners LLC
Tenzing Acquisition Corp.
Pharmaceuticals
2020
Form of Assumed Option
Tenzing Acquisition Corp.
Pharmaceuticals
CA
2020
Letter Agreement, dated as of March 15, 2016, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc
Tenzing Acquisition Corp.
Pharmaceuticals
2020
Letter Agreement, dated as of October 28, 2015, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc
Tenzing Acquisition Corp.
Pharmaceuticals
2020
Form of Backstop Agreement, by and among Tenzing Acquisition Corp., Reviva Pharmaceuticals, Inc., and the Investor named therein
Tenzing Acquisition Corp.
Pharmaceuticals
NY
2020
Lock-Up Agreement, dated as of July 20, 2020 by and among Dr. Bhat, Tenzing and the Purchaser Representative
Tenzing Acquisition Corp.
Pharmaceuticals
NY
2020
Form of Lock-Up Agreement (General)
Tenzing Acquisition Corp.
Pharmaceuticals
NY
2020
Description of the Registrants securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
Tenzing Acquisition Corp.
Pharmaceuticals
2020
Letter Agreement, dated August 20, 2018, by and among the Company, its officers, its directors and the Sponsor
Tenzing Acquisition Corp.
Pharmaceuticals
2018
Form of Indemnity Agreement
Tenzing Acquisition Corp.
Pharmaceuticals
NY
2018
Form of Letter Agreement among the Registrant and each of the sponsor, directors and officers of the Registrant
Tenzing Acquisition Corp.
Pharmaceuticals
2018
Specimen Ordinary Shares Certificate
Tenzing Acquisition Corp.
Pharmaceuticals
2018
Specimen Unit Certificate
Tenzing Acquisition Corp.
Pharmaceuticals
2018